Menu

SMEIPO

LG Electronics’ India unit IPO: valuation, strategy and sector implications

Investor Frenzy: Chemkart, Smarten IPOs 5x Oversubscribed!

Investor Frenzy: Chemkart, Smarten IPOs 5x Oversubscribed!

High demand in the SME sector drives the Chemkart and Smarten Power IPOs, with allotments anticipated by July 10 and listings scheduled for July 14.

Summary:
The initial public offerings (IPOs) of Chemkart India and Smarten Power Systems have seen robust investor participation, each getting subscribed over five times their offer size. Allotment for both issues will be finalised by July 10, with shares set to debut on the BSE SME and NSE Emerge platforms on July 14.

IPO Boom in SME Space: Chemkart India and Smarten Power Systems Shine
The small and medium enterprise (SME) IPO space in India continues to witness strong traction as two recent public issues—Chemkart India and Smarten Power Systems—have both recorded over 5x subscription, signalling elevated investor enthusiasm for promising growth stories in niche sectors.
The subscription window for both IPOs closed recently, and investors are now eagerly awaiting the allotment status, which will be finalised by July 10, 2025. Chemkart India Ltd’s shares are set to be listed on the BSE SME platform, while Smarten Power Systems Ltd will make its debut on the NSE Emerge platform on July 14, 2025.

Chemkart India IPO: Interest Generated by Speciality Chemicals and API Focus
Company Overview:
Chemkart India is a rapidly growing chemical distribution company catering to the Active Pharmaceutical Ingredients (API) and speciality chemicals segment. With a wide customer base and strong supplier partnerships, the company provides critical raw materials for industries ranging from pharmaceuticals to agrochemicals and paints.
IPO Details:
Issue Size: ₹27.04 crore
Price Band: ₹99–₹105 per share
Lot Size: 1,200 shares
Use of Proceeds: Working capital requirements, general corporate purposes, and expansion of warehousing infrastructure.
Investor Response:
The Chemkart IPO was subscribed more than 5.3 times, driven largely by retail investors and HNIs, who accounted for the lion’s share of the bids. The company’s scalable business model, strong financials, and projected revenue growth made it attractive for investors betting on India’s booming chemical and pharmaceutical sectors.

Smarten Power Systems IPO: Riding the Clean Energy Wave
Company Overview:
Smarten Power Systems is a manufacturer of renewable energy products such as solar inverters, batteries, and power backup solutions. The company has witnessed rapid growth amid rising demand for energy-efficient and eco-friendly power solutions, particularly in rural and semi-urban India.
IPO Details:
Issue Size: ₹38.5 crore
Price Band: ₹96–₹102 per share
Lot Size: 1,200 shares
Use of Proceeds: Capital expenditure, R&D, marketing initiatives, and working capital.
Investor Response:
Smarten Power’s IPO was subscribed over 5.7 times, with significant traction from institutional investors betting on the green energy transition. The company’s strong product portfolio, growing distribution network, and alignment with government solar initiatives contributed to the robust response.

What Happens Next: Allotment & Listing Timeline
For both Chemkart and Smarten Power IPOs, the share allotment status is scheduled to be finalised by July 10, 2025. Refunds for shares that were not allotted will be processed by July 11, and the credit for allotted shares in the demat account is anticipated by July 13.
Listing Date for Both IPOs: July 14, 2025
Chemkart India: To be listed on BSE SME
Smarten Power Systems: To be listed on NSE Emerge
Investors should verify the allotment status on the official registrar websites or stock exchange portals.

Market Outlook: Why SME IPOs Are Gaining Traction
The SME IPO sector in India has experienced a revival in investor interest over the last two years. This is fueled by:
Improved financial disclosure norms
High-growth potential of niche companies
Reduced entry barriers for retail investors
Attractive valuations compared to mainboard IPOs
Chemkart and Smarten Power’s oversubscription reaffirms the sentiment that quality SMEs with solid fundamentals and strong growth narratives are capable of delivering multibagger returns post-listing.

Analyst Take:
Market analysts are optimistic about the listing performance of both companies. Given the high demand and investor interest, a robust opening is expected.
“Both companies operate in sectors aligned with structural growth trends—pharma for Chemkart and clean energy for Smarten Power. Post-listing performance will depend on their earnings trajectory and execution capabilities,” said Radhika Seth, a senior equity strategist at an investment firm.

Risks to Watch:
While investor interest is high, experts caution that SME stocks are generally less liquid and more volatile than mainboard stocks. Hence, long-term fundamentals and governance should remain the key drivers of investment decisions.

Conclusion:
The enthusiastic response to Chemkart India and Smarten Power Systems’ IPOs marks yet another successful chapter in India’s growing SME capital market story. With strong fundamentals, favourable sector outlooks, and investor optimism, these companies are poised to attract attention post-listing. However, investors should temper short-term listing expectations with long-term business performance and scalability.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The image added is for representation purposes only

Rupee Plummets Amid FII Outflows, Trade Concerns

India’s year-end IPO blitz: risks, rewards and what to watchIndia’s year-end IPO blitz: risks, rewards and what to watch

Influx Healthtech IPO: Strong Demand on Day 1!

Influx Healthtech IPO: Strong Demand on Day 1!

The ₹55.63 crore SME IPO of Influx Healthtech opens to investor interest amid solid grey market premium; analysts watch subscription numbers and market sentiment for early cues.

Summary:
Influx Healthtech launched its initial public offering (IPO) on June 18, targeting ₹55.63 crore via the SME route. The initial public offering (IPO), valued between ₹91 and ₹96 per share, is set to close on June 21, with shares expected to start trading on the NSE SME on June 25. Early interest, reflected in grey market premiums, suggests investor optimism. This article explores key IPO details, valuation, GMP trends, risk factors, and what investors should watch before applying.

IPO Overview: Influx Healthtech Hits the Market
Influx Healthtech Limited, a technology-focused company in the healthcare industry, launched its SME IPO for public subscription on June 18, 2025. The firm aims to raise ₹55.63 crore through a fresh issuance of equity shares. The price range is set between ₹91 and ₹96 per share, with investors able to bid in lots of 1,200 shares, requiring a minimum investment of ₹1,15,200 at the upper end of the price band.
The IPO will be open for subscription until June 21. Allotment details will be finalized by June 23, and shares are anticipated to be credited to demat accounts by June 24. The company’s shares are expected to start trading on the NSE SME platform on June 25.

Company Profile: A Tech-Driven Healthcare Innovator
Influx Healthtech Limited operates at the intersection of technology and healthcare, offering a suite of health-tech services ranging from AI-powered diagnostics, telemedicine platforms, to digital patient management systems. The company focuses on digitizing the healthcare value chain by working with hospitals, diagnostic labs, and individual practitioners.
Their platforms aim to solve key inefficiencies in the healthcare sector, such as patient engagement, appointment scheduling, and diagnostic result delivery. Given the rising demand for healthcare digitization in India and globally, Influx Healthtech is attempting to tap into a high-growth niche.

IPO Structure and Utilization of Proceeds
The ₹55.63 crore IPO is a 100% fresh issue, with no offer for sale (OFS) component. This means that all the proceeds will directly go to the company for its growth and expansion plans. According to the red herring prospectus:
₹20 crore will be used for technology upgradation and product development.
₹15 crore is allocated for marketing and client acquisition.
₹10 crore for infrastructure expansion, including setting up regional offices.
The remaining funds will go towards working capital and general corporate purposes.

Financials Snapshot
As per the company’s financial disclosures:
Revenue for FY24 stood at ₹35.8 crore, up from ₹24.3 crore in FY23 — a YoY growth of 47%.
Profit After Tax (PAT) rose to ₹6.9 crore in FY24 from ₹4.1 crore in FY23.
The company has achieved a robust EBITDA margin of 18.6%, highlighting its operational efficiency.
Debt levels are minimal, improving their financial risk profile ahead of listing.

Grey Market Premium (GMP) and Market Sentiment
As of Day 1, market observers report a Grey Market Premium (GMP) of ₹20–₹24 per share, indicating that the IPO is likely to list at a premium of 20–25% over the upper price band of ₹96.
The GMP trend reflects strong investor confidence and favourable sentiment towards tech-enabled SME companies. However, investors must be cautious as GMP is unofficial and speculative in nature.

Key Dates to Remember
EventDate
IPO Opening Date June 18, 2025
IPO Closing Date June 21, 2025
Basis of Allotment June 23, 2025
Credit of Shares June 24, 2025
Listing on NSE SME June 25, 2025

Valuation & Peer Comparison
At the upper price band of ₹96, Influx Healthtech is valued at a P/E ratio of around 20x based on FY24 earnings. This valuation is competitive when compared to other tech-based SMEs in the health sector, such as Docmode Health or Medtech Solutions, which are trading at P/E multiples of 25–30x.
Analysts suggest that while the valuation appears reasonable, growth sustainability and execution in the B2B health-tech domain will be critical for long-term gains.

Risk Factors to Consider
Despite the strong growth trajectory, investors should note the following risks:
Client concentration risk – a significant portion of revenue comes from a handful of hospital networks.
Tech dependency – any breach, bug, or tech downtime could significantly impact operations.
Regulatory challenges in healthcare data privacy and compliance could arise with scale.
Limited track record – while growth is visible, the company is still in the early stages of scale.

Analyst Views
Brokerage firms tracking the SME IPO space have issued a “Subscribe with Caution” recommendation. While the company’s strong growth, lean balance sheet, and sectoral tailwinds are promising, the relatively short operating history and high competitive intensity in health tech raise concerns.
Retail investors with a moderate risk appetite and long-term view may consider subscribing to the issue.

Conclusion
Influx Healthtech’s IPO comes at a time when digital transformation in the healthcare industry is accelerating. With a niche presence, healthy financials, and reasonable pricing, the IPO has generated justified market interest. However, investors must weigh the growth prospects against sector-specific risks and evolving regulatory frameworks.

 

 

 

:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The image added is for representation purposes only

Foxconn Strengthens India Presence Amid Global Asset Shift

India’s year-end IPO blitz: risks, rewards and what to watchIndia’s year-end IPO blitz: risks, rewards and what to watch

Virtual Galaxy Infotech IPO Soars: Over 200x Subscribed!

Virtual Galaxy Infotech IPO Soars: Over 200x Subscribed!

Virtual Galaxy Infotech’s IPO was oversubscribed 200 times, indicating strong investor interest. Allotment results and a high grey market premium suggest potential listing gains.

Summary:

Virtual Galaxy Infotech’s IPO, valued at ₹93.29 crore, witnessed tremendous interest from investors, exceeding subscriptions 200 times across retail, high-net-worth individuals (HNI), and institutional sectors. With the allotment set to be finalized today and a grey market premium (GMP) of ₹53 indicating a substantial upside, investors are on edge. The public offering included a fresh issue of 6.57 million equity shares, with the listing scheduled for May 19. The excitement about the IPO reflects a renewed confidence in the market towards technology-driven companies fueled by optimistic feelings within the SME sector.

Virtual Galaxy Infotech IPO: A Stellar Debut in Primary Markets

Virtual Galaxy Infotech, a promising digital solutions provider, has captured investors’ imaginations with its dazzling Initial Public Offering (IPO). With a subscription rate exceeding 200 times, the IPO has set a new benchmark for enthusiasm in the small and medium enterprise (SME) IPO space in 2024–25.
The ₹93.29 crore issue drew aggressive bids from retail investors, non-institutional investors (NIIs), and qualified institutional buyers (QIBs), signaling broad-based confidence in the company’s business model, growth trajectory and sectoral relevance. With the allotment results anticipated to be completed today, the IPO has become the center of attention on Dalal Street.

Investor Demand: High Interest Across All Categories

The initial public offering (IPO) involved issuing 6.57 million new equity shares at a predetermined price to support the company’s working capital needs, expand infrastructure, and upgrade technology. The offering began on May 13 and concluded on May 15, with a remarkable turnout on the last day of bidding.
– Retail Category: Subscribed over 180 times
– NII/HNI Category: Subscriptions exceeded 250 times.
– QIB Category: Subscribed around 120 times
This overwhelming demand has surprised market experts, and Virtual Galaxy Infotech has established itself as one of the most highly sought-after IPOs in the recent SME market.

Grey Market Premium Soars: A Listing Day Pop Expected

In the unlisted market, the stock has a Grey Market Premium (GMP) of ₹53 per share, suggesting a potential upside of 70–80% on the listing price if the current trend continues until the listing day on May 19, 2025. The GMP reflects that market participants expect a robust debut driven by a company’s supply and digital growth story mismatch. A GMP at this level is commonly interpreted as a sign of market sentiment, and in this instance, the outlook is strongly positive.

Company Overview: Tech-Driven Growth in a Digitally Hungry Market

Virtual Galaxy Infotech is a technology solutions provider specializing in software development, digital transformation, IT consulting, and AI-driven enterprise services. The company has established a strong presence among MSMEs and mid-sized businesses looking to embrace digitalization.
Their range of services includes:
– Cloud-based enterprise solutions
– Custom software solutions tailored to retail, banking, financial services, and insurance (BFSI) sectors.
– ERP and CRM integration specifically for SMEs
– AI and automation-enhanced business analytics
In FY23, the company achieved impressive top-line growth of over 45% of the company’s year, benefiting from expanding margins fueled by high-value digital transformation projects and strong client retention. The robust client portfolio, a healthy order book, and aspirations to diversify into AI and machine learning-based platforms were significant factors that attracted investor interest.

Utilization of IPO Proceeds

Virtual Galaxy Infotech intends to use the funds raised from the IPO for the following purposes:
– Upgrading technology and enhancing infrastructure
– Recruiting skilled professionals to aid the company
– Establishing offshore delivery centers
– Increasing working capital
– Addressing general corporate needs
These efforts aim to enhance capacity and expedite the company’s evolution into a scalable IT solutions partner for clients worldwide.

What Makes the IPO Stand Out?

Stellar Growth Metrics: The company has demonstrated steady revenue and profit growth over the last three fiscal years.
Asset-Light Model: Focusing on services, the company sustains high margins while keeping capital expenditures low.
High Entry Barriers: Its technological expertise and long-term client relationships provide a significant competitive advantage.
Digital Tailwinds: The increasing digitization of Indian businesses benefits Virtual Galaxy Infotech.
Attractive Valuation: Even with strong demand, the IPO was priced interest from retail and high-net-worth investors.

Allotment Status and Next Steps for Investors

The allocation for the IPO is expected to be completed on May 16. Applicants can check their status via the BSE India IPO Allotment page, the registrar’s portal (e.g., Bigshare Services Pvt Ltd), or notifications from their brokers.
Successful applicants will have shares credited to their demat accounts by May 18, a day before listing, while refunds for unsuccessful applicants are also likely to be processed at that time.
The strong demand for the Virtual Galaxy Infotech IPO signifies renewed optimism in India’s tech and SME sectors, particularly among retail investors. This oversubscription indicates an increasing interest in specialized technology companies and may motivate more SMEs to raise funds through primary markets. Brand storytelling and market timing are crucial to an IPO’s success.

Conclusion: A Star is Born in the SME Galaxy

Virtual Galaxy Infotech’s 200x subscription has left investors starry-eyed and market watchers stunned. The company seems poised for sustained growth with a tech-centric business model, innovative use of IPO funds, and a strong digital services pipeline.
As Infotech counts down to the allotment and listing, all eyes are on whether the stock will match or exceed its grey market expectations. Virtual Galaxy could become a blueprint for SME tech IPOs in India going forward if it does.

 

 

 

 

 

 

The image added is for representation purposes only

Rallis India Announces 250% Dividend Amid Stable Growth Trajectory